Global ETD Search

41	Hepatitis C Virus Screening in Federally Qualified Health Centers in Rural Appalachia Olanrewaju, Folawiyo S, Falodun, Ayotola, Jawla, Muhammed, Vanhook, Patricia, McKenzie, Stacey 12 April 2019 (has links) The prevalence of Hepatitis C Virus (HCV) in the US is estimated at 3.5 million with 18,153 deaths in 2016. It is the most common bloodborne infection, with a higher age-adjusted mortality rate than Hepatitis B Virus or Human Immunodeficiency Virus. Without treatment, nearly 1.1 million people will die from HCV by 2060. About 41,200 new cases of HCV were reported in 41 states in the US in 2016. The reported cases of acute HCV in 2016 is 2.3 per 100,000 in Tennessee, which is more than twice the national goal set by Healthy People 2020. This is a descriptive study to ascertain the HCV prevalence and usefulness of screening in medical outreach settings (MO) compared to indigent healthcare clinics (IHC) in northeast Tennessee. This study period was from April 2017 – February 2019. Participants (n=250), were adults, who engaged in routine, opt-out HCV testing at 4 IHC and 3 MO sites in the Tri-Cities, TN region. During the screening, demographic information- age, gender, race- were collected and the de-identified data were analyzed using Statistical Analysis System (SAS 9.3) to perform a descriptive analysis. Also, several discrete Chi-Square tests of independence between the demographic variables, screening locations, and HCV antibody prevalence was conducted. A total of 250 clients were screened for HCV. The majority of clients screened were non-Hispanic whites 228 (91.20%); females 136 (54.40%); young adults 131 (52.40%) and at IHC clinics 187 (74.80%). Screening showed HCV antibody prevalence of 14.8%. The majority of positive cases were non-Hispanic whites 36 (97.30%; P=0.1561); females 19 (51.35%; P=0.6867) and young adults 23 (62.16%; P=0.286). The prevalence at the IHC clinics and MO settings were 36 (97.30%; P=0.0006) and 1(2.70%) respectively. This analysis shows the higher yield of targeted HCV screening at IHC clinics. Focused HCV screening is critical in the era of opioid epidemic, particularly when direct-acting antiviral agents (DAAs) which offer a Sustained Virologic Response (SVR) rate of more than 90% are available. The use of case control or cohort study designs to establish causality is recommended for improving focused HCV screening. Hepatitis C virus infection Hepatitis C virus screening Opioid epidemic Baby Boomers Direct-Acting Antiviral agents Liver Functions Viral Infections Rural Health Community Health Health of Underserved Populations Health Services Delivery Medical Intervention Methods Minority Health Patient Care and Education Public Health Inflammation Infectious Diseases Communicable Diseases Chronic Illnesses Cancer or Carcinogenesis Reproductive System
42	Development of a Guideline for Hospice Staff, Patients, and Families on Appropriate Opioid Use Alexander-Goreá, Trenika 01 January 2017 (has links) There is an identified problem with patients receiving suboptimal pain management at a hospice agency in the northwestern United States. At this agency, undertreatment of pain is prevalent. Evidence indicates that this may be a result of a lack of guidelines, education, and knowledge of appropriate prescribing. Known barriers to the correct prescription and administration of potent opioids in the hospice setting include prevailing beliefs, knowledge, skills, and attitudes, all of which can impact care negatively. Contextually, hospice principles mandate patient comfort and caregiver involvement in continuous quality improvement, which includes adequate and informed pain management. Moreover, hospice metrics demand requisite knowledge, skills, and attitudes for optimal care, including pain management at the end of life. The Academic Center for Evidence-Based Practice (ACE) star model was used to guide the development of an evidence-based, guideline-supported educational program that will improve pain management at the hospice agency when implemented. The purpose of this project was to use transdisciplinary expertise and team collaboration to develop the program and then to conduct a formative and summative evaluation utilizing experts to prepare the guidelines and process for implementation. Ten experts reviewed the guideline, the educational materials, the process, and the evaluation plan and conducted reviews using the AGREE II tool. The panel of experts agreed within the 6 AGREE domains. Future implementation of this guideline, translation process, and evaluation tool will impact social change through the empowerment of the clinical staff, patients, and caregivers to provide the best pain control and comfort at end of life, a vulnerable time for all patients. comfort care practitioners dying evidence-based practice EBP death theory concept guideline transdisciplinary multidiciplinary ethical end-of-life care EOLC Appropriate Opioid Use hospice hospice care palliative care palliate palliation end-of-life EOL actively dying opioid epidemic opioid crisis opioids prescribing opioids and practitioners pain control pain management clinical practice guideline hospice guidance Ethics and Political Philosophy Nursing

Search results

Hepatitis C Virus Screening in Federally Qualified Health Centers in Rural Appalachia

Development of a Guideline for Hospice Staff, Patients, and Families on Appropriate Opioid Use